NCT06561880
- Conditions
- AML, FLT3 Gene Mutation
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
AML
Explore clinical trials studying AML. Study availability and eligibility vary by location and protocol.
137 public trials
43 recruiting studies
AML trial results
Recruiting
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
NCT06611839
- Conditions
- AML, IDH1 Mutation, Treatment
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Recruiting
Cardioprotection in AML
NCT04977180
- Conditions
- AML, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT06158828
- Conditions
- AML, AML, Childhood, Acute Myeloid Leukemia, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT07493538
- Conditions
- AML, Acute Leukemia, Acute Myeloid Leukemia, +10 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT06001788
- Conditions
- AML, AML With Mutated NPM1, Acute Leukemia, +14 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCLA Health - Bowyer Oncology Center Los Angeles, California, United States
- UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
NCT06047886
- Conditions
- ALL, AML, Bone Marrow Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT05735717
- Conditions
- AML, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
- Locations
-
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
NCT06834282
- Conditions
- AML, Acute Myeloid Leukemia, Hematologic Diseases, +7 more
- Locations
-
- University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Sarah Cannon Research Insitute Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06744504
- Conditions
- AML, RUNX1-RUNX1T1 Fusion Protein Expression
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China